Total intravenous anesthesia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1: Aged between 18 and 65 years 2: Patients undergoing elective laparoscopic total abdominal hysterectomy under gynecological general anesthesia 3: Anesthesiologists (ASA) physical status 1-II 4: Body Mass Index between 18 and 30 5: Written informed consent
Exclusion criteria
Exclusion criteria: 1: Significant liver and kidney diseases, psycho-nervous system diseases, heart failure, respiratory failure, etc 2: Severe arrhythmias: if there is a history of A-S syndrome, pre-excitation syndrome, or active dysrhythmia, concurrent treatment with Grade I antiarrhythmic drugs or amiodarone for less than 3 months 3: acute porphyria 4: Family history of malignant hyperthermia 5: Egg or soy allergy ; A history of allergy or hypersensitivity to the investigational drug that may be used in the study 6: Long-term use of sedatives or antidepressants 7: Inability to communicate or cooperate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The average dose of ciprofol; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative recovery quality;Safety and efficacy of intraoperative general anesthesia; | — |
Countries
China
Contacts
Nanfang Hospital of Southern Medical University